Non-NPV-exercise group | NPV-exercise group | |||
---|---|---|---|---|
Baseline | 12 weeks | Baseline | 12 weeks | |
(n = 18) | (n = 18) | (n = 18) | (n = 18) | |
FVC, % predicted | 37.7 ± 2.4 | 37.9 ± 3.2 | 32.6 ± 2.8 | 35.1 ± 2.7a |
FEV1, % predicted | 42.2 ± 2.9 | 43.9 ± 4.3 | 36.9 ± 3.2 | 40.3 ± 3.3a |
FEV1/FVC, % | 84.1 ± 8.6 | 83.6 ± 7.8 | 82.9 ± 9.4 | 83.5 ± 10.8 |
6MWD, m | 362.8 ± 99.4 | 330.3 ± 94.4 | 371.3 ± 77.9 | 405.4 ± 78.1a |
SaO2, % pre/post 6MWT | 94.0/ 81.4 | 93.2/ 76.8 | 93.9/ 77.0 | 94.6/ 79.1 |
HR, pre/ post 6MWT | 98.2/ 125.8 | 101.4/ 127.7 | 103.3/ 126.7 | 92.0/ 123.4 |
Borg, pre/ post 6MWT | 0.5/ 5.0 | 1.5/ 7.0 | 1.25/ 5.0 | 0/ 4.5a |
(range) | (0–4)/ (3–10) | (0–4)/ (2–9) | (0–4)/ (4–8) | (0–4)/ (1–8) |
Limb muscle power | ||||
R-upper limb, lb | 32.9 ± 1.8b | 32.3 ± 1.6b | 31.0 ± 2.1c | 33.5 ± 2.2a, c |
L-upper limb, lb | 30.2 ± 3.5b | 33.0 ± 4.7b | 29.6 ± 1.6c | 30.3 ± 1.6c |
R-low limb, lb | 44.3 ± 3.9b | 46.2 ± 4.9b | 38.5 ± 3.0c | 41.4 ± 2.3c |
L-low limb. lb | 41.2 ± 3.4b | 41.3 ± 4.6b | 38.2 ± 2.7c | 40.7 ± 2.2c |
SGRQ | ||||
Symptom score | 48.2 ± 6.0e | 46.5 ± 6.1e | 54.6 ± 5.0 | 24.5 ± 4.0a |
Active score | 61.6 ± 6.0e | 72.3 ± 6.1e | 53.7 ± 5.8 | 45.9 ± 5.6a |
Impacts score | 30.0 ± 4.2e | 46.7 ± 7.0a,e | 36.2 ± 5.7 | 22.6 ± 5.1a |
Total score | 42.6 ± 4.6e | 54.4 ± 4.9e | 44.6 ± 4.8 | 30.0 ± 4.4a |